Metabolic response to hypertonic glucose administration in Reye syndrome.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 666261)

Published in Ann Neurol on March 01, 1978

Authors

M W Haymond, I E Karl, J P Keating, D C DeVivo

Articles by these authors

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg (1978) 7.57

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med (1999) 7.24

Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol (2001) 4.49

Mitochondrial myopathies. Ann Neurol (1985) 3.81

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58

Glycogen storage disease in adults. Ann Intern Med (1994) 3.58

Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A (1999) 3.35

Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med (1997) 2.97

Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol (1999) 2.92

Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol (1994) 2.82

Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med (1976) 2.72

A failed assay opened a new door in growth hormone research. Endocrinology (1992) 2.69

Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest (1989) 2.69

Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20

Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA (1992) 2.19

Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15

Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med (1998) 2.02

Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes (1977) 2.02

Alanine and glutamine synthesis and release from skeletal muscle. I. Glycolysis and amino acid release. J Biol Chem (1976) 1.87

Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med (2000) 1.85

Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol (1983) 1.82

Chronic ketosis and cerebral metabolism. Ann Neurol (1978) 1.76

Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest (1980) 1.71

Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock (1997) 1.71

Norepinephrine: hormone and neurotransmitter in man. Am J Physiol (1978) 1.66

The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest (1976) 1.63

Alanine and glutamine synthesis and release from skeletal muscle. II. The precursor role of amino acids in alanine and glutamine synthesis. J Biol Chem (1976) 1.59

The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol (1993) 1.53

Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr (1990) 1.51

Role of CuZn superoxide dismutase in regulating lymphocyte apoptosis during sepsis. Crit Care Med (2000) 1.48

Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest (1987) 1.47

Inhibition of NO synthesis in septic shock. Lancet (1992) 1.46

Validation of two-pool model for in vivo ketone body kinetics. Am J Physiol (1990) 1.46

Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am J Physiol (1985) 1.42

Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Environ Mass Spectrom (1990) 1.41

Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest (1984) 1.34

Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem (1984) 1.33

Alanine and glutamine synthesis and release from skeletal muscle. IV. beta-Adrenergic inhibition of amino acid release. J Biol Chem (1976) 1.33

Epitrochlearis muscle. I. Mechanical performance, energetics, and fiber composition. Am J Physiol (1980) 1.32

A microfluorometric enzymatic assay for the determination of alanine and pyruvate in plasma and tissues. J Lab Clin Med (1972) 1.32

Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol (1985) 1.31

Recurrent childhood myoglobinuria. Adv Pediatr (1990) 1.31

Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism (1980) 1.28

Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med (1980) 1.28

Hypoglycemia in infancy and childhood. II. J Pediatr (1973) 1.28

The clinical and radiological features of cholecystocolic fistulae. Br J Radiol (1996) 1.28

Role of arginine in health and in renal disease. Am J Physiol (1994) 1.26

Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest (1991) 1.26

An animal model for the ketogenic diet. Epilepsia (1974) 1.24

Hypoglycemia in infancy and childhood. I. J Pediatr (1973) 1.24

A progressive neurologic syndrome in children with chronic liver disease. N Engl J Med (1981) 1.23

Clinical manifestations of mitochondrial DNA depletion. Neurology (1998) 1.22

Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab (1991) 1.21

Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects. Diabetologia (1983) 1.20

Alanine and glutamine synthesis and release from skeletal muscle. III. Dietary and hormonal regulation. J Biol Chem (1976) 1.19

Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest (1990) 1.17

Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. Am J Clin Nutr (1991) 1.14

Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J Clin Endocrinol Metab (1992) 1.14

Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med (1984) 1.14

Increased gluconeogenic substrates in the small-for-gestational-age infant. N Engl J Med (1974) 1.14

Pseudomembranous colitis associated with ampicillin therapy. Am J Dis Child (1974) 1.13

Perforated stress ulcers in infants. J Pediatr Surg (1981) 1.12

Prandial insulin requirements in insulin-dependent diabetics: effects of size, time of day, and sequence of meals. J Clin Endocrinol Metab (1983) 1.12

Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science (2001) 1.11

Mitochondrial diseases. Neurol Clin (1989) 1.11

Proceedings: Parenchymatous degeneration of the central nervous system in childhood leukemia. Cancer (1974) 1.11

Acute acalculous cholecystitis. Complication of other illnesses in childhood. Arch Surg (1975) 1.10

Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans. Am J Physiol (1992) 1.08

Infantile methemoglobinemia caused by carrot juice. N Engl J Med (1973) 1.08

Ketotic hypoglycemia: an amino acid substrate limited disorder. J Clin Endocrinol Metab (1974) 1.08

Daily periodicity of susceptibility of mice to pneumococcal infection. Nature (1969) 1.06

Mitochondrial myopathies. J Inherit Metab Dis (1987) 1.06

Human crowding and personal control: an integration of the research. Psychol Bull (1979) 1.05

Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res (2001) 1.05

Measurement of branched chain amino acids and branched chain alpha-ketoacids in plasma by high-performance liquid chromatography. J Chromatogr (1982) 1.05

Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res (1996) 1.05

Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man. Am J Physiol (1980) 1.04

Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery (1999) 1.04

Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis? Proc Natl Acad Sci U S A (1993) 1.04

Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man. J Clin Invest (1983) 1.04

Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol (1989) 1.04

Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. Proc Natl Acad Sci U S A (1995) 1.04

Origin of chi46,XX/46,XY chimerism in a human true hermaphrodite. Science (1980) 1.03

The alpha-keto acids of branched-chain amino acids: simplified derivatization for physiological samples and complete separation as quinoxalinols by packed column gas chromatography. Anal Biochem (1980) 1.03

Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.02

Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest (1986) 1.02

Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology (1994) 1.02

Beta-ketothiolase deficiency as a cause of the "ketotic hyperglycinemia syndrome". Pediatrics (1974) 1.02

Quantitative analysis of regenerating and degenerating areas within the lobule of the carbon tetrachloride-injured liver. Arch Biochem Biophys (1965) 1.02

Association of Crohn disease and Turner syndrome. J Pediatr (1978) 1.00

Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats. J Clin Invest (1975) 1.00

Prepyloric gastric antral web: a puzzling epidemic. J Pediatr Surg (1978) 1.00

Antral diaphragm--a cause of gastric outlet obstruction in infants and children. J Pediatr (1977) 1.00

Cytokine blockade in sepsis--Are two better than one? Crit Care Med (2001) 0.99

Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease. Stroke (1991) 0.99

Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes (1999) 0.99

Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade. Am J Physiol (1979) 0.99

Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Proc Natl Acad Sci U S A (1994) 0.98